Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

9.9K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
9.9K
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

956
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
956
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

420
Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
420

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bright Ferritin for Non-Invasive MRI Monitoring of the Fate of Transplanted hPSC-Cardiomyocytes in the Infarcted Rat Heart.

Magnetic resonance in medicine·2026
Same author

Molecular Magnetic Resonance Imaging Visualizes Nitric Oxide Dynamics in a Mouse Model of Acute Myocardial Inflammation.

ACS sensors·2025
Same author

A Fibrosis-Targeting T<sub>1</sub> MRI Contrast Agent Synthesized via Photooxidative Self-Desulfurization of Porphyrin Thiourea.

ACS sensors·2025
Same author

Predictive signal modeling and multi-rate filtering in accelerated cardiac MRI.

Magnetic resonance in medicine·2025
Same author

Time-course manganese chloride biodistribution and manganese-induced MRI contrast in mouse organs.

Magnetic resonance in medicine·2025
Same author

Accelerated dynamic magnetic resonance imaging from Spatial-Subspace Reconstructions (SPARS).

PloS one·2025

Related Experiment Video

Updated: Feb 18, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

10.6K

A scale to measure MRI contrast agent sensitivity.

Rohan D A Alvares1,2, Daniel A Szulc1,2, Hai-Ling M Cheng3,4,5,6,7

  • 1Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.

Scientific Reports
|November 16, 2017
PubMed
Summary

A new scale ranks magnetic resonance imaging (MRI) contrast agents by efficiency. This metric, based on minimum detectable concentration, aids in selecting optimal agents for research and clinical use.

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

10.9K

Related Experiment Videos

Last Updated: Feb 18, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

10.6K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

10.9K

Area of Science:

  • Medical Imaging
  • Radiology
  • Biomedical Engineering

Background:

  • Magnetic resonance imaging (MRI) is a key modality for anatomical and soft tissue visualization.
  • Contrast agents enhance MRI specificity but require systematic efficiency evaluation.
  • Diverse MRI contrast agents necessitate a standardized method for comparison.

Purpose of the Study:

  • To introduce a novel scale for ranking MRI contrast agent efficiency.
  • To establish a universal metric for assessing contrast agent sensitivity.
  • To facilitate the selection and application of effective MRI contrast agents.

Main Methods:

  • Analytically determining the minimum detectable concentration of contrast agents.
  • Employing a ratiometric approach to standardize efficiency against a benchmark agent.
  • Validating the scale using several model contrast agents.

Main Results:

  • A new scale for ranking MRI contrast agent sensitivity was developed.
  • Relative sensitivity of model contrast agents was compared for the first time.
  • The scale provides a standardized method for assessing contrast efficiency.

Conclusions:

  • The developed scale offers a universal metric for MRI contrast agent sensitivity.
  • This metric will aid in the assessment and promotion of diverse contrast agents.
  • The scale is crucial for advancing research and clinical applications of MRI contrast agents.